SEK 0.87
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.29 SEK | 52.46% |
2022 | -0.61 SEK | 50.0% |
2021 | -1.22 SEK | 83.1% |
2020 | -7.22 SEK | -142.28% |
2019 | -2.98 SEK | -42.58% |
2018 | -2.09 SEK | -46.15% |
2017 | -1.43 SEK | -17.21% |
2016 | -1.22 SEK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.02 SEK | 29.08% |
2024 Q2 | -0.01 SEK | 43.0% |
2023 FY | - SEK | 52.46% |
2023 Q2 | -0.02 SEK | 90.32% |
2023 Q3 | -0.02 SEK | -8.7% |
2023 Q4 | -0.03 SEK | -41.0% |
2023 Q1 | -0.19 SEK | -46.15% |
2022 Q2 | -0.24 SEK | 25.0% |
2022 FY | - SEK | 50.0% |
2022 Q4 | -0.13 SEK | 27.78% |
2022 Q3 | -0.18 SEK | 25.0% |
2022 Q1 | -0.32 SEK | 17.95% |
2021 Q4 | -0.39 SEK | 4.88% |
2021 FY | - SEK | 83.1% |
2021 Q3 | -0.41 SEK | 0.0% |
2020 FY | - SEK | -142.28% |
2019 FY | - SEK | -42.58% |
2018 FY | - SEK | -46.15% |
2017 FY | - SEK | -17.21% |
2016 FY | - SEK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
BrainCool AB (publ) | -0.29 SEK | -0.0% |
Neola Medical AB (publ) | -0.16 SEK | -81.25% |